DDI Study of Etravirine and GSK1265744

Clinical trial NCT00920296 · COMPLETED

Trial details

NCT number: NCT00920296
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Infection, Human Immunodeficiency Virus

Start date: 2009-07-01
Primary completion: 2009-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.